Cyclacel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cyclacel Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | CYCC | Q1 | -$7.05 | — | — | — | $0.00 | — | — | — | Get Alert |
03/19/2024 | PM | CYCC | Q4 | -$9.00 | -$5.89 | -$6.23 | -5.77% | $0.00 | — | $31.00K | — | Get Alert |
11/13/2023 | PM | CYCC | Q3 | -$6.30 | -$5.40 | -$7.35 | -36.11% | $0.00 | — | $0.00 | — | Get Alert |
08/09/2023 | PM | CYCC | Q2 | -$6.90 | -$7.50 | -$6.60 | 12.00% | $0.00 | — | $373.00K | — | Get Alert |
05/11/2023 | PM | CYCC | Q1 | -$6.30 | -$9.90 | -$7.05 | 28.79% | $0.00 | — | $0.00 | — | Get Alert |
03/06/2023 | PM | CYCC | Q4 | -$8.10 | -$7.20 | -$9.00 | -25.00% | $0.00 | — | $0.00 | — | Get Alert |
11/09/2022 | PM | CYCC | Q3 | -$8.10 | -$8.40 | -$6.30 | 25.00% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2022 | PM | CYCC | Q2 | -$8.40 | -$8.25 | -$6.90 | 16.36% | $0.00 | — | $0.00 | — | Get Alert |
05/11/2022 | PM | CYCC | Q1 | -$7.50 | -$10.20 | -$6.30 | 38.24% | $0.00 | — | $0.00 | — | Get Alert |
03/28/2022 | PM | CYCC | Q4 | -$20.10 | -$9.75 | -$8.10 | 16.92% | $0.00 | — | $0.00 | — | Get Alert |
11/10/2021 | PM | CYCC | Q3 | -$7.05 | -$9.75 | -$8.10 | 16.92% | $0.00 | — | $0.00 | — | Get Alert |
08/11/2021 | PM | CYCC | Q2 | -$8.70 | -$7.50 | -$8.40 | -12.00% | $0.00 | — | $0.00 | — | Get Alert |
05/12/2021 | PM | CYCC | Q1 | -$22.20 | -$7.35 | -$7.50 | -2.04% | $0.00 | — | $0.00 | — | Get Alert |
02/25/2021 | PM | CYCC | Q4 | -$42.00 | -$7.65 | -$20.10 | -162.75% | $0.00 | — | $0.00 | — | Get Alert |
11/11/2020 | PM | CYCC | Q3 | -$33.00 | -$8.25 | -$7.05 | 14.55% | $0.00 | — | $0.00 | — | Get Alert |
08/12/2020 | PM | CYCC | Q2 | -$33.00 | -$7.05 | -$8.70 | -23.40% | $0.00 | — | $0.00 | — | Get Alert |
05/12/2020 | PM | CYCC | Q1 | -$42.00 | -$43.50 | -$22.20 | 48.97% | $0.00 | — | $0.00 | — | Get Alert |
02/26/2020 | PM | CYCC | Q4 | -$51.00 | -$39.00 | -$42.00 | -7.69% | $150.00K | — | $0.00 | — | Get Alert |
11/13/2019 | PM | CYCC | Q3 | -$54.00 | -$48.00 | -$33.00 | 31.25% | $0.00 | — | $0.00 | — | Get Alert |
Cyclacel Pharmaceuticals (CYCC) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 19, 2024 for Q4.
The Actual EPS was $-6.23, which missed the estimate of $-5.89.
The Actual Revenue was $31K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.